1. Home
  2. SGMT vs OXM Comparison

SGMT vs OXM Comparison

Compare SGMT & OXM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sagimet Biosciences Inc. Series A

SGMT

Sagimet Biosciences Inc. Series A

HOLD

Current Price

$8.00

Market Cap

648.1M

Sector

N/A

ML Signal

HOLD

Logo Oxford Industries Inc.

OXM

Oxford Industries Inc.

SELL

Current Price

$26.47

Market Cap

543.0M

ML Signal

SELL

Company Overview

Basic Information
Metric
SGMT
OXM
Founded
2006
1942
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
648.1M
543.0M
IPO Year
2021
1994

Fundamental Metrics

Financial Performance
Metric
SGMT
OXM
Price
$8.00
$26.47
Analyst Decision
Buy
Hold
Analyst Count
12
6
Target Price
$27.91
★ $34.00
AVG Volume (30 Days)
★ 1.4M
581.6K
Earning Date
11-12-2026
09-03-2026
Dividend Yield
N/A
★ 10.04%
EPS Growth
★ N/A
N/A
EPS
N/A
★ 4.25
Revenue
$2,000,000.00
★ $1,477,834,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$2.29
P/E Ratio
★ N/A
$6.56
Revenue Growth
★ N/A
N/A
52 Week Low
$4.50
$24.20
52 Week High
$11.45
$49.58

Technical Indicators

Market Signals
Indicator
SGMT
OXM
Relative Strength Index (RSI) 37.31 43.05
Support Level $6.21 $24.20
Resistance Level $11.33 $42.57
Average True Range (ATR) 0.56 1.05
MACD -0.14 0.55
Stochastic Oscillator 16.37 57.12

Price Performance

Historical Comparison
SGMT
OXM

About SGMT Sagimet Biosciences Inc. Series A

Sagimet Biosciences Inc a clinical-stage biopharmaceutical company developing novel therapeutics called fatty acid synthase (FASN) inhibitors that target dysfunctional metabolic and fibrotic pathways in diseases resulting from the overproduction of the fatty acid, palmitate. Its drug candidate, denifanstat, is an oral, once-daily pill and selective FASN inhibitor in development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), acne and select forms of cancer. Its second FASN inhibitor, TVB-3567, is a potent and selective small molecule FASN inhibitor in development for acne. It operates as a single business segment, developing and commercializing therapeutics for the treatment of MASH and other diseases where FASN plays a pathogenic role.

About OXM Oxford Industries Inc.

Oxford Industries Inc is an apparel manufacturing company that designs, sources, markets, and distributes products under the brand name Tommy Bahama, and Lilly Pulitzer. Tommy Bahama designs, sources, markets, and distributes men's and women's sportswear and related products. Lilly Pulitzer designs, sources, markets, and distributes upscale collections of women's and women's dresses, sportswear, and related products. The company's business is organized as: Tommy Bahama, Lilly Pulitzer, Johnny Was and Emerging Brands reportable segments. Geographically, the company operates in United States as well as Internationally.

Share on Social Networks: